This month our scientists have reported results from several studies, all of which could lead to more effective treatments for cancer patients.
One group has explored a new drug combo that could make cancer cells more sensitive to chemotherapy. Their work could also explain why some patients respond better than others to a type of drug known as taxanes.
Manchester researchers mapped the genetics of an anonymous leukaemia patient, showing how it could be possible to personalise therapy for individuals with the disease.
Overcoming treatment resistance in lung cancer is a step closer thanks to research that investigated why a promising anti-cancer agent has little effect on the most common lung tumours.